Medtronic Plc (MDT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Medtronic Plc (MDT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH738D
  • |
  • Pages: 122
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Medtronic Plc (Medtronic), formerly Medtronic, Inc., is a medical technology company. It develops, manufactures and markets a wide range of medical devices, therapies and services for the treatment of conditions such as heart disease, spinal conditions, neurological disorders, vascular disease, orthopedic disorders and diabetes. The company sells its products through direct sales force in the US and a combination of direct sales representatives and independent distributors outside the US. The company serves hospitals, clinics, third-party health care providers, distributors, and institutions including governmental health care programs and group purchasing organizations (GPOs) in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.

Medtronic Plc (MDT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Medtronic Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

Medtronic Plc, Medical Devices Deals, 2011 to YTD 2017 12

Medtronic Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14

Medtronic Plc, Pharmaceuticals & Healthcare, Deal Details 17

Asset Purchase 17

Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For USD6 Million 17

Venture Financing 18

MD Start Secures USD11.5 Million in Venture Funding 18

Semma Therapeutics Raises USD44 Million in Series A Financing 19

AcuFocus Raises USD21 Million in Venture Financing 20

Sapheon Raises USD20 Million In Series B Financing 22

Intersect ENT Raises USD30 Million In Series D Financing 23

Visualase Secures USD5.2 Million in Series B Funding 25

Spinal Modulation Secures USD30 Million In Series D Financing 26

Partnerships 28

Sanofi Enters into Co-Development Agreement with Medtronic 28

Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 29

Arca Biopharma Enters Into Co-Development Agreement With Medtronic For Gencaro 30

Medtronic Plans To Enter Into Agreement With Pharma Companies For Alzheimer's 31

Aircraft Medical Enters Into Distribution Agreement With Covidien For McGRATH MAC Video Laryngoscope 32

Eli Lilly Enters Into Collaboration With Medtronic 34

Nile Therapeutics Enters Into An Agreement With Medtronic 35

Licensing Agreements 36

Acorda Therapeutics Enters Into Licensing Agreement With Medtronic For AC105 36

Equity Offering 38

GI Dynamics Completes Private Placement Of CHESS Depository Interests For USD21 Million 38

Tengion Completes Private Placement Of Shares For USD31.4 Million 40

Debt Offering 42

Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045 42

Medtronic Raises USD500 Million in Private Placement of Notes Due 2020 43

Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022 44

Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025 45

Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035 46

Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018 47

Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020 48

Medtronic Completes Public Offering Of Notes Due 2044 For USD650 Million 49

Medtronic Completes Public Offering Of Notes Due 2017 For USD250 Million 51

Medtronic Completes Public Offering Of Notes Due 2024 For USD850 Million 53

Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For USD250 Million 55

Covidien Completes Public Offering Of Notes Due 2023 For USD750 Million 57

Covidien Completes Private Placement Of Notes Due 2018 For USD300 Million 59

Covidien Completes Private Placement Of Notes Due 2023 For USD600 Million 60

Medtronic Completes Public Offering Of Notes Due 2043 For USD750 Million 61

Medtronic Completes Public Offering Of Notes Due 2023 For USD1.25 Billion 63

Medtronic Completes Public Offering Of Notes Due 2018 For USD1 Billion 65

Covidien Completes Public Offering Of Senior Notes Due 2022 For USD650 Million 67

Covidien Completes Public Offering Of Senior Notes Due 2015 For USD600 Million 68

Medtronic Completes Public Offering Of 3.125% Senior Notes Due 2022 For USD675 Million 69

Medtronic Completes Public Offering Of 4.5% Senior Notes Due 2042 For USD400 Million 71

Medtronic Completes Public Offering Of Senior Notes Due 2021 For USD500 Million 73

Medtronic Completes Public Offering Of Senior Notes Due 2016 For USD500 Million 74

Asset Transactions 75

Spectranetics Acquires Stellarex from Covidien for USD30 Million 75

Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 76

Covidien Plans to Divest Vascular Therapies Business 77

Acquisition 78

Medtronic Acquires Diabeter 78

Medtronic Acquires Covidien for USD49.9 Billion 79

Medtronic May Acquire Smith & Nephew 81

Medtronic Plc-Key Competitors 82

Medtronic Plc-Key Employees 83

Medtronic Plc-Locations And Subsidiaries 85

Head Office 85

Other Locations & Subsidiaries 85

Recent Developments 95

Strategy And Business Planning 95

Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 95

Financial Announcements 96

May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 96

Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 99

Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 102

Aug 25, 2016: Medtronic Reports First Quarter Financial Results 105

May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 108

Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 111

Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 113

Corporate Communications 114

May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 114

Legal and Regulatory 115

Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 115

Government and Public Interest 116

Sep 20, 2016: National Patient Safety Foundation's Lucian Leape Institute Awarded $1 Million Grant from Medtronic 116

Sep 13, 2016: Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California 117

Other Significant Developments 118

Nov 24, 2016: S-CAPE and Medtronic Unveil State-of-the-art Operating Rooms in Spain 118

Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 119

Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 120

Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 121

Appendix 122

Methodology 122

About GlobalData 122

Contact Us 122

Disclaimer 122

List of Figures

Medtronic Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Medtronic Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

Medtronic Plc, Medical Devices Deals, 2011 to YTD 2017 12

List of Tables

Medtronic Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Medtronic Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Medtronic Plc, Deals By Therapy Area, 2011 to YTD 2017 10

Medtronic Plc, Medical Devices Deals, 2011 to YTD 2017 12

Medtronic Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14

Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For USD6 Million 17

MD Start Secures USD11.5 Million in Venture Funding 18

Semma Therapeutics Raises USD44 Million in Series A Financing 19

AcuFocus Raises USD21 Million in Venture Financing 20

Sapheon Raises USD20 Million In Series B Financing 22

Intersect ENT Raises USD30 Million In Series D Financing 23

Visualase Secures USD5.2 Million in Series B Funding 25

Spinal Modulation Secures USD30 Million In Series D Financing 26

Sanofi Enters into Co-Development Agreement with Medtronic 28

Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 29

Arca Biopharma Enters Into Co-Development Agreement With Medtronic For Gencaro 30

Medtronic Plans To Enter Into Agreement With Pharma Companies For Alzheimer's 31

Aircraft Medical Enters Into Distribution Agreement With Covidien For McGRATH MAC Video Laryngoscope 32

Eli Lilly Enters Into Collaboration With Medtronic 34

Nile Therapeutics Enters Into An Agreement With Medtronic 35

Acorda Therapeutics Enters Into Licensing Agreement With Medtronic For AC105 36

GI Dynamics Completes Private Placement Of CHESS Depository Interests For USD21 Million 38

Tengion Completes Private Placement Of Shares For USD31.4 Million 40

Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045 42

Medtronic Raises USD500 Million in Private Placement of Notes Due 2020 43

Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022 44

Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025 45

Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035 46

Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018 47

Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020 48

Medtronic Completes Public Offering Of Notes Due 2044 For USD650 Million 49

Medtronic Completes Public Offering Of Notes Due 2017 For USD250 Million 51

Medtronic Completes Public Offering Of Notes Due 2024 For USD850 Million 53

Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For USD250 Million 55

Covidien Completes Public Offering Of Notes Due 2023 For USD750 Million 57

Covidien Completes Private Placement Of Notes Due 2018 For USD300 Million 59

Covidien Completes Private Placement Of Notes Due 2023 For USD600 Million 60

Medtronic Completes Public Offering Of Notes Due 2043 For USD750 Million 61

Medtronic Completes Public Offering Of Notes Due 2023 For USD1.25 Billion 63

Medtronic Completes Public Offering Of Notes Due 2018 For USD1 Billion 65

Covidien Completes Public Offering Of Senior Notes Due 2022 For USD650 Million 67

Covidien Completes Public Offering Of Senior Notes Due 2015 For USD600 Million 68

Medtronic Completes Public Offering Of 3.125% Senior Notes Due 2022 For USD675 Million 69

Medtronic Completes Public Offering Of 4.5% Senior Notes Due 2042 For USD400 Million 71

Medtronic Completes Public Offering Of Senior Notes Due 2021 For USD500 Million 73

Medtronic Completes Public Offering Of Senior Notes Due 2016 For USD500 Million 74

Spectranetics Acquires Stellarex from Covidien for USD30 Million 75

Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 76

Covidien Plans to Divest Vascular Therapies Business 77

Medtronic Acquires Diabeter 78

Medtronic Acquires Covidien for USD49.9 Billion 79

Medtronic May Acquire Smith & Nephew 81

Medtronic Plc, Key Competitors 82

Medtronic Plc, Key Employees 83

Medtronic Plc, Other Locations 85

Medtronic Plc, Subsidiaries 85

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Medtronic Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 15958
Site License
USD 500 INR 31915
Corporate User License
USD 750 INR 47873

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com